Search research articles
Contact Us
Filters
Showing results (1-10 of 959) with videos related to
Page
of 96
Sort By:
Cancer Research Communications
|
August 27, 2025
Preclinical activity of Datopotamab deruxtecan (Dato-DXd), an antibody-drug conjugate targeting TROP2, in poorly differentiated endometrial carcinomas
Niccolo G Santin, Namrata Sethi, Stefania Bellone, et al.
Cancer Research Communications
|
August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 Unit
Camila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Cancer Research Communications
|
November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations
Radhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Cancer Research Communications
|
October 10, 2022
Pathway-based approach reveals differential sensitivity to E2F1 inhibition in glioblastoma
Alvaro G Alvarado, Kaleab Tessema, Sree Deepthi Muthukrishnan, et al.
Cancer Research Communications
|
February 14, 2022
Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics
Yang Gao, Elena B Kabotyanski, Jonathan H Shepherd, et al.
Cancer Research Communications
|
April 21, 2023
Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
Fumiyoshi Okano, Takanori Saito, Yoshitaka Minamida, et al.
Cancer Research Communications
|
April 17, 2023
Structurally Complex Osteosarcoma Genomes Exhibit Limited Heterogeneity within Individual Tumors and across Evolutionary Time
Sanjana Rajan, Simone Zaccaria, Matthew V Cannon, et al.
Cancer Research Communications
|
April 10, 2023
The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells
Grazia Ambrosini, Christopher A Natale, Elgilda Musi, et al.
Cancer Research Communications
|
March 31, 2023
Probabilistic Mixture Models Improve Calibration of Panel-derived Tumor Mutational Burden in the Context of both Tumor-normal and Tumor-only Sequencing
Jordan Anaya, John-William Sidhom, Craig A Cummings, et al.
Cancer Research Communications
|
October 31, 2022
NetrinG1<sup>+</sup> cancer-associated fibroblasts generate unique extracellular vesicles that support the survival of pancreatic cancer cells under nutritional stress
Kristopher S Raghavan, Ralph Francescone, Janusz Franco-Barraza, et al.
Page
of 96
Search research articles
Search
Showing results (1-10 of 959) with videos related to
Sort By:
Page
of 96
Cancer Research Communications
|
August 27, 2025
Preclinical activity of Datopotamab deruxtecan (Dato-DXd), an antibody-drug conjugate targeting TROP2, in poorly differentiated endometrial carcinomas
Niccolo G Santin, Namrata Sethi, Stefania Bellone, et al.
Cancer Research Communications
|
August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 Unit
Camila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Cancer Research Communications
|
November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations
Radhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Cancer Research Communications
|
October 10, 2022
Pathway-based approach reveals differential sensitivity to E2F1 inhibition in glioblastoma
Alvaro G Alvarado, Kaleab Tessema, Sree Deepthi Muthukrishnan, et al.
Cancer Research Communications
|
February 14, 2022
Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics
Yang Gao, Elena B Kabotyanski, Jonathan H Shepherd, et al.
Cancer Research Communications
|
April 21, 2023
Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
Fumiyoshi Okano, Takanori Saito, Yoshitaka Minamida, et al.
Cancer Research Communications
|
April 17, 2023
Structurally Complex Osteosarcoma Genomes Exhibit Limited Heterogeneity within Individual Tumors and across Evolutionary Time
Sanjana Rajan, Simone Zaccaria, Matthew V Cannon, et al.
Cancer Research Communications
|
April 10, 2023
The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells
Grazia Ambrosini, Christopher A Natale, Elgilda Musi, et al.
Cancer Research Communications
|
March 31, 2023
Probabilistic Mixture Models Improve Calibration of Panel-derived Tumor Mutational Burden in the Context of both Tumor-normal and Tumor-only Sequencing
Jordan Anaya, John-William Sidhom, Craig A Cummings, et al.
Cancer Research Communications
|
October 31, 2022
NetrinG1<sup>+</sup> cancer-associated fibroblasts generate unique extracellular vesicles that support the survival of pancreatic cancer cells under nutritional stress
Kristopher S Raghavan, Ralph Francescone, Janusz Franco-Barraza, et al.
Page
of 96